18 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Summary Acute AIDP ... Pathophysiology ... : • Immune response ... preceding infection ... Treatment: • Plasmapheresis
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Pathogenesis: • Immune ... • Immune response ... the underlying pathophysiology ... and cauda equina TREATMENT
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Immune Reconstitution ... of HIV/AIDS patients ... be present: • AIDS ... Lymphadenitis, pulmonary ... albicans • Epstein Barr
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
impaired cellular immune ... , Advanced HIV/AIDS ... presentations: • Pulmonary ... this morphology Treatment ... Diagnosis #Management #treatment
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... →Activation of CD8 ... that disrupts immune ... Others: Cellular immune ... Unknown cause Treatment
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Infection in ... HIV / AIDS - Differential ... Antimicrobial treatment ... required until immune ... differential #diagnosis #AIDS
Immune Reconstitution Inflammatory Syndrome (IRIS) - Pathophysiology
Risk factors:
 - Low CD4 count
 - Disseminated OI
 -
Syndrome (IRIS) - Pathophysiology ... factors: - Low CD4 ... duration or OI treatment ... Syndrome #IRIS #Pathophysiology ... #AIDS
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Progression: (+) Immune ... rest LTBI (-) Immune ... Tuberculosis Treatment ... Initiating Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Progression: (+) Immune ... rest LTBI (-) Immune ... Tuberculosis Treatment ... Initiating Treatment
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
host): • Chronic pulmonary ... Histoplasmosis Treatment ... yeast • At risk: AIDS ... Aspergillosis Pathophysiology ... : • Pulmonary (